These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32216644)

  • 41. Genome-scale analysis identifies GJB2 and ERO1LB as prognosis markers in patients with pancreatic cancer.
    Zhu T; Gao YF; Chen YX; Wang ZB; Yin JY; Mao XY; Li X; Zhang W; Zhou HH; Liu ZQ
    Oncotarget; 2017 Mar; 8(13):21281-21289. PubMed ID: 28177904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autophagy Regulatory Genes MET and RIPK2 Play a Prognostic Role in Pancreatic Ductal Adenocarcinoma: A Bioinformatic Analysis Based on GEO and TCGA.
    Li X; Li Z; Zhu H; Yu X
    Biomed Res Int; 2020; 2020():8537381. PubMed ID: 33204717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Matrix Metalloproteinase 11 as a Novel Tumor Promoter and Diagnostic and Prognostic Biomarker for Pancreatic Ductal Adenocarcinoma.
    Zhang X; Lu J; Zhou L; You L; Liang Z; Guo J; Zhao Y
    Pancreas; 2020 Jul; 49(6):812-821. PubMed ID: 32590618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma.
    Luan H; He Y; Zhang T; Su Y; Zhou L
    BMC Cancer; 2022 Apr; 22(1):463. PubMed ID: 35477379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential molecular mechanisms.
    Zhou X; Liao X; Wang X; Huang K; Yang C; Yu T; Han C; Zhu G; Su H; Han Q; Chen Z; Huang J; Gong Y; Ruan G; Ye X; Peng T
    Cancer Med; 2020 Feb; 9(3):859-871. PubMed ID: 31808619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identity of MMP1 and its effects on tumor progression in head and neck squamous cell carcinoma.
    Zhang G; Li T; Tan G; Song Y; Liu Q; Wang K; Ai J; Zhou Z; Li W
    Cancer Med; 2022 Jun; 11(12):2516-2530. PubMed ID: 35426219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integration of mRNA and protein expression data for the identification of potential biomarkers associated with pancreatic ductal adenocarcinoma.
    Akrami S; Tahmasebi A; Moghadam A; Ramezani A; Niazi A
    Comput Biol Med; 2023 May; 157():106529. PubMed ID: 36921457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of significant prognostic risk markers for pancreatic ductal adenocarcinoma: a bioinformatic analysis.
    Zhang Z; Sun W; Zeng Z; Lu Y
    Acta Biochim Pol; 2022 Jun; 69(2):327-333. PubMed ID: 35675627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of Key Genes Involved in Pancreatic Ductal Adenocarcinoma with Diabetes Mellitus Based on Gene Expression Profiling Analysis.
    Zhou W; Wang Y; Gao H; Jia Y; Xu Y; Wan X; Zhang Z; Yu H; Yan S
    Pathol Oncol Res; 2021; 27():604730. PubMed ID: 34257566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Possible Molecular Markers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Shen Q; Yu M; Jia JK; Li WX; Tian YW; Xue HZ
    Med Sci Monit; 2018 Apr; 24():2368-2376. PubMed ID: 29671412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
    Li Y; Su Z; Wei B; Qin M; Liang Z
    Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of key pathways and gene changes in primary pancreatic stellate cells after cross-talk with pancreatic cancer cells (BXPC-3) using bioinformatics analysis.
    Tang D; Wu Q; Yuan Z; Xu J; Zhang H; Jin Z; Zhang Q; Xu M; Wang Z; Dai Z; Fang H; Li Z; Lin C; Shi C; Xu M; Sun X; Wang D
    Neoplasma; 2019 May; 66(3):446-458. PubMed ID: 30784291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.
    Zhao L; Zhao H; Yan H
    BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma.
    Lu H; Niu F; Liu F; Gao J; Sun Y; Zhao X
    Cancer Med; 2017 Jun; 6(6):1181-1191. PubMed ID: 28440066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
    Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
    BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long non-coding RNAs expressed in pancreatic ductal adenocarcinoma and lncRNA BC008363 an independent prognostic factor in PDAC.
    Li J; Liu D; Hua R; Zhang J; Liu W; Huo Y; Cheng Y; Hong J; Sun Y
    Pancreatology; 2014; 14(5):385-90. PubMed ID: 25200694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of multidimensional data to identify the molecular biomarker for pancreatic ductal adenocarcinoma.
    Zhuang L; Qi Y; Wu Y; Liu N; Fu Y
    Biomed Res Int; 2013; 2013():798054. PubMed ID: 24171174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LncRNA co-expression network analysis reveals novel biomarkers for pancreatic cancer.
    Giulietti M; Righetti A; Principato G; Piva F
    Carcinogenesis; 2018 Jul; 39(8):1016-1025. PubMed ID: 29796634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis.
    Manoochehri M; Wu Y; Giese NA; Strobel O; Kutschmann S; Haller F; Hoheisel JD; Moskalev EA; Hackert T; Bauer AS
    Mol Oncol; 2020 Jun; 14(6):1252-1267. PubMed ID: 32243066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.